Edition:
United States

Healthcare

JNJ.N
PFE.N
MRK.N

BRIEF-Chongqing Taiji expects 2016 net profit to rise about 305.2 pct

* Says it expects 2016 net profit to rise about 305.2 percent y/y to 940 million yuan ($137.07 million)

5:29am EST

BT slump weighs on European, UK indexes; Generali rallies

* Generali jumps on deal chatter (Adds quote and detail, updates prices)

BRIEF-Vincent Medical's unit and Inovytec enter into agreement

* Inovytec shall issue and allot to VMIL an aggregate of 12,091 series a preferred shares Source text for Eikon: Further company coverage:

4:55am EST

BRIEF-Enanta pharmaceuticals says EMA grants accelerated assessment for Abbvie's investigational HCV regimen of Glecaprevir/Pibrentasvir

* Says EMA grants accelerated assessment for Abbvie's investigational HCV Regimen Of Glecaprevir/Pibrentasvir

BRIEF-Albert David appoints Tarminder Parmar as CEO

* Says appointed Tarminder Singh Parmar as the chief executive officer (CEO) of the company with effect from January 24, 2017, in place of H. P. Kabra

4:43am EST
Healthcare
Johnson & Johnson $113.91 -0.21%
Pfizer Inc $31.46 -0.98%
Merck & Co Inc $61.81 -1.15%

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.